Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCKIES: Roxadustat vs Epoetin Alfa in Dialysis Anemia
NCT02174731Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by AstraZeneca. Started Jul 2014; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02174731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174731.